Literature DB >> 32072427

The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention.

Abdelmagid M Elmatboly1, Ahmed M Sherif2, Dalia A Deeb2, Amira Benmelouka3, May N Bin-Jumah4, Lotfi Aleya5, Mohamed M Abdel-Daim6,7.   

Abstract

Aggregation of particular proteins in the form of inclusion bodies or plaques followed by neuronal death is a hallmark of neurodegenerative proteopathies such as primary Parkinsonism, Alzheimer's disease, Lou Gehrig's disease, and Huntington's chorea. Complex polygenic and environmental factors implicated in these proteopathies. Accumulation of proteins in these disorders indicates a substantial disruption in protein homeostasis (proteostasis). Proteostasis or cellular proteome homeostasis is attained by the synchronization of a group of cellular mechanisms called the proteostasis network (PN), which is responsible for the stability of the proteome and achieves the equilibrium between synthesis, folding, and degradation of proteins. In this review, we will discuss the different types of PN and the impact of PN component dysfunction on the four major neurodegenerative diseases mentioned earlier. Graphical abstract.

Entities:  

Keywords:  Autophagy; Heat-shock proteins; Neurodegeneration; Proteostasis; Proteotoxicity; Ubiquitin-proteasome system

Mesh:

Year:  2020        PMID: 32072427     DOI: 10.1007/s11356-020-07914-1

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  307 in total

1.  Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.

Authors:  Ana Maria Cuervo; Leonidas Stefanis; Ross Fredenburg; Peter T Lansbury; David Sulzer
Journal:  Science       Date:  2004-08-27       Impact factor: 47.728

Review 2.  Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

Authors:  Rachel J Harding; Yu-Feng Tong
Journal:  Acta Pharmacol Sin       Date:  2018-04-05       Impact factor: 6.150

3.  Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death.

Authors:  Chantal Sellier; Maria-Letizia Campanari; Camille Julie Corbier; Angeline Gaucherot; Isabelle Kolb-Cheynel; Mustapha Oulad-Abdelghani; Frank Ruffenach; Adeline Page; Sorana Ciura; Edor Kabashi; Nicolas Charlet-Berguerand
Journal:  EMBO J       Date:  2016-04-21       Impact factor: 11.598

Review 4.  Alzheimer's Disease: A Review from the Pathophysiology to Diagnosis, New Perspectives for Pharmacological Treatment.

Authors:  Leide Caroline Dos Santos Picanco; Priscilla F Ozela; Maiara de Fatima de Brito Brito; Abraao A Pinheiro; Elias C Padilha; Francinaldo S Braga; Carlos Henrique Tomich de Paula da Silva; Cleydson Breno Rodrigues Dos Santos; Joaquín M C Rosa; Lorane Izabel da Silva Hage-Melim
Journal:  Curr Med Chem       Date:  2018       Impact factor: 4.530

5.  Polyglutamine tracts regulate autophagy.

Authors:  Avraham Ashkenazi; Carla F Bento; Thomas Ricketts; Mariella Vicinanza; Farah Siddiqi; Mariana Pavel; Ferdinando Squitieri; Maarten C Hardenberg; Sara Imarisio; Fiona M Menzies; David C Rubinsztein
Journal:  Autophagy       Date:  2017-07-19       Impact factor: 16.016

6.  Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.

Authors:  Sami J Barmada; Gaia Skibinski; Erica Korb; Elizabeth J Rao; Jane Y Wu; Steven Finkbeiner
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

Review 7.  Mitochondria in Huntington's disease.

Authors:  Maria Damiano; Laurie Galvan; Nicole Déglon; Emmanuel Brouillet
Journal:  Biochim Biophys Acta       Date:  2009-08-11

8.  UCHL1 is a Parkinson's disease susceptibility gene.

Authors:  Demetrius M Maraganore; Timothy G Lesnick; Alexis Elbaz; Marie-Christine Chartier-Harlin; Thomas Gasser; Rejko Krüger; Nobutaka Hattori; George D Mellick; Aldo Quattrone; Jun-Ichi Satoh; Tatsushi Toda; Jian Wang; John P A Ioannidis; Mariza de Andrade; Walter A Rocca; Taksushi Toda
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

Review 9.  GSK-3β, a pivotal kinase in Alzheimer disease.

Authors:  María Llorens-Martín; Jerónimo Jurado; Félix Hernández; Jesús Avila
Journal:  Front Mol Neurosci       Date:  2014-05-21       Impact factor: 5.639

10.  Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.

Authors:  Anna Migdalska-Richards; Liam Daly; Erwan Bezard; Anthony H V Schapira
Journal:  Ann Neurol       Date:  2016-11       Impact factor: 10.422

View more
  1 in total

Review 1.  Protein synthesis modulation as a therapeutic approach for amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Santiago E Charif; M Florencia Vassallu; Lara Salvañal; Lionel M Igaz
Journal:  Neural Regen Res       Date:  2022-07       Impact factor: 5.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.